Education and Training Core
教育培训核心
基本信息
- 批准号:10327937
- 负责人:
- 金额:$ 9.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-26 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY: RESEARCH EDUCATION CORE
The goal of the Meharry Medical College/Vanderbilt-Ingram Cancer Center/Tennessee State Cancer Partnership
(MVTCP) Research Education Program is to facilitate the growth and career development of a new population
of outstanding underrepresented minority (URM) cancer researchers. Our current Pathway to Discovery program
begins with cancer research education for high school students, continues for undergraduate Biology/Chemistry
majors at Tennessee State University (TSU) and culminates with support for graduate students (PhD, MSPH
and MPH) at Meharry Medical College (MMC) and TSU. The program also includes research support for medical
students at MMC and Vanderbilt University (VU). This program has proven to be very successful in supporting
the progression of a diverse population of students into cancer research careers. We propose to enhance the
efficacy of the Pathway to Discovery program by including psychosocial resources derived from social cognitive
career theory (SCCT). Research experience will engage students in the development and evolution of self-
efficacy (SE) as well as a sense of being part of the scientific research community [science identity (SI)]. SCCT
research shows that strong SE and SI are especially crucial to URM students entering and completing the
necessary programs to pursue research careers, including cancer research. We propose a program grounded
in SCCT that provides psychosocial resources and research experiences needed to develop and sustain SE and
SI. MVTCP is particularly suited to target African American and Latinx undergraduate students (at TSU),
graduate (at TSU and MMC) and medical students (at MMC). High school students come from two local STEM
magnet schools with predominant URM student populations. To achieve our goals, we propose the following
aims: 1) Provide psychosocial resources for high school (8 students, 4 juniors and 4 seniors) and undergraduate
students (12 students, 3 at each level freshmen through seniors) engaged in continuous academic year and
summer cancer research experiences to ensure development of SI and SE by leveraging the cancer research
and support resources at our Partnership institutions. Development of SE and SI will be accomplished by
providing opportunities for laboratory research and communities of practice (CoP) and a series of workshops
based in SCCT. 2) Recruit and support a diverse population of graduate students (2 MPH/3 PhD students each
year) who will evolve, strengthen and maintain a strong SI and SE as they engage in cancer research with the
ultimate goal of enhancing the diversity of the cancer research workforce. SCCT-based workshops and
resources targeted at the evolution and maintenance of SE and SI in our graduate students will be implemented.
3) Provide educational research opportunities, workshops and CoP to medical students (4 students each year
at MMC/4 at VU) to ensure successful evolution, strengthening and maintenance of their SI and SE and to
sustain their interest in clinical population sciences and translational cancer research with a focus on disparities.
项目摘要:研究教育核心
梅哈里医学院/范德比尔特 - 伊格兰癌症中心/田纳西州癌症伙伴关系的目标
(MVTCP)研究教育计划旨在促进新人群的成长和职业发展
出色代表性不足的少数民族(URM)癌症研究人员。我们目前的发现途径
从针对高中生的癌症研究教育开始,继续为本科生物学/化学
田纳西州立大学(TSU)的大满贯,并在支持研究生的支持下达到顶峰(PhD,MSPH
和MPH)在Meharry医学院(MMC)和TSU。该计划还包括医学研究支持
MMC和范德比尔特大学(VU)的学生。事实证明,该计划在支持方面非常成功
多样化的学生晋升为癌症研究职业。我们建议增强
通过包括从社会认知衍生的社会心理资源来启用发现途径的疗效
职业理论(SCCT)。研究经验将使学生参与自我的发展和发展
功效(SE)以及成为科学研究界的一部分[科学身份(SI)]的感觉。 SCCT
研究表明,强大的SE和SI对于进入和完成的URM学生尤其重要
从事研究职业的必要计划,包括癌症研究。我们提出了一个扎根的计划
在SCCT中提供了开发和维持SE所需的社会心理资源和研究经验
SI。 MVTCP特别适合针对非裔美国人和拉丁语本科生(在TSU),
研究生(在TSU和MMC)和医学生(在MMC)。高中生来自两个当地的茎
拥有URM学生人数的磁铁学校。为了实现我们的目标,我们提出以下内容
目的:1)为高中(8名学生,4名大三和4年级)和本科生提供社会心理资源
学生(通过老年人在每个级别的新生中有12名学生)参加了不断的学年和
通过利用癌症研究来确保SI和SE发展的夏季癌症研究经验
并在我们的合伙机构中支持资源。 SE和SI的发展将由
为实验室研究和实践社区(COP)和一系列研讨会提供机会
基于SCCT。 2)招募和支持各种各样的研究生(每个2英里/3位博士生
一年)谁将在与他们一起进行癌症研究时发展,增强和保持强大的SI和SE
提高癌症研究人员多样性的最终目标。基于SCCT的研讨会和
将实施针对我们研究生中SE和SI的进化和维护的资源。
3)向医学生提供教育研究机会,讲习班和COP(每年4名学生
在VU的MMC/4处
维持他们对临床人群科学和转化癌症研究的兴趣,重点是差异。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Samuel Evans Aduny...的其他基金
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)
MMC、VICC
- 批准号:85347278534727
- 财政年份:2011
- 资助金额:$ 9.37万$ 9.37万
- 项目类别:
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
MMC、VICC
- 批准号:1001275710012757
- 财政年份:2011
- 资助金额:$ 9.37万$ 9.37万
- 项目类别:
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
MMC、VICC
- 批准号:93564579356457
- 财政年份:2011
- 资助金额:$ 9.37万$ 9.37万
- 项目类别:
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
MMC、VICC
- 批准号:92116389211638
- 财政年份:2011
- 资助金额:$ 9.37万$ 9.37万
- 项目类别:
1/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities
1/3) MMC、VICC 和 TSU:消除癌症差异的合作伙伴
- 批准号:1049341710493417
- 财政年份:2011
- 资助金额:$ 9.37万$ 9.37万
- 项目类别:
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
MMC、VICC
- 批准号:97650419765041
- 财政年份:2011
- 资助金额:$ 9.37万$ 9.37万
- 项目类别:
1/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities
1/3) MMC、VICC 和 TSU:消除癌症差异的合作伙伴
- 批准号:1070508910705089
- 财政年份:2011
- 资助金额:$ 9.37万$ 9.37万
- 项目类别:
相似国自然基金
细胞尺度空间分辨下的癌症分子生物学精准测量
- 批准号:
- 批准年份:2020
- 资助金额:300 万元
- 项目类别:专项基金项目
基于生物学通路网络的癌症标志物识别方法研究
- 批准号:62072145
- 批准年份:2020
- 资助金额:57 万元
- 项目类别:面上项目
USP22调控癌症代谢重编程的分子机制及生物学功能研究
- 批准号:
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
微浸润腺癌的分子特征研究
- 批准号:81872290
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
整合多组学数据系统识别调控免疫事件进而驱动癌症转移的关键因子
- 批准号:81802926
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Elucidating novel epigenetic modifications implicated in multiple myeloma risk disparities
阐明与多发性骨髓瘤风险差异相关的新型表观遗传修饰
- 批准号:1091219110912191
- 财政年份:2023
- 资助金额:$ 9.37万$ 9.37万
- 项目类别:
The Meharry Cancer Summer Research Program (SuRP)
梅哈里癌症夏季研究计划 (SuRP)
- 批准号:1071529110715291
- 财政年份:2023
- 资助金额:$ 9.37万$ 9.37万
- 项目类别:
Full Project 1: Defining Mechanisms of MICAL-dependent Pancreatic Cancer Cell Migration
完整项目 1:MICAL 依赖性胰腺癌细胞迁移的定义机制
- 批准号:1076227310762273
- 财政年份:2023
- 资助金额:$ 9.37万$ 9.37万
- 项目类别:
Role of YB1 in health disparities in triple negative breast cancer
YB1 在三阴性乳腺癌健康差异中的作用
- 批准号:1065594310655943
- 财政年份:2023
- 资助金额:$ 9.37万$ 9.37万
- 项目类别: